Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Federal Trade Commission
Merck
QuintilesIMS
Cantor Fitzgerald
Covington
Accenture
Chubb

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DAYTRANA

« Back to Dashboard

Clinical Trials for Daytrana

Trial ID Title Status Sponsor Phase Summary
NCT00434213 Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA Completed Noven Therapeutics Phase 4 This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
NCT00499863 Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD Completed Noven Therapeutics Phase 3 To assess the efficacy and safety of efficacy of MTS compared to placebo
NCT00501293 Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD Completed Noven Therapeutics Phase 3 To evaluate the long-term, safety of Methylphenidate Transdermal System (MTS) in aged 13-17 years diagnosed withADHD
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Daytrana

Condition Name

Condition Name for Daytrana
Intervention Trials
Attention Deficit Hyperactivity Disorder 6
ADHD 3
Attention Deficit Disorder With Hyperactivity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Daytrana
Intervention Trials
Attention Deficit Disorder with Hyperactivity 10
Hyperkinesis 8
Delayed Emergence from Anesthesia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Daytrana

Trials by Country

Trials by Country for Daytrana
Location Trials
United States 67
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Daytrana
Location Trials
Virginia 4
Ohio 4
Tennessee 3
Michigan 3
New Jersey 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Daytrana

Clinical Trial Phase

Clinical Trial Phase for Daytrana
Clinical Trial Phase Trials
Phase 4 4
Phase 3 4
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Daytrana
Clinical Trial Phase Trials
Completed 9
Unknown status 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Daytrana

Sponsor Name

Sponsor Name for Daytrana
Sponsor Trials
Noven Therapeutics 3
Shire 2
Medical University of South Carolina 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Daytrana
Sponsor Trials
Other 10
Industry 5
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chubb
Fuji
Harvard Business School
Cantor Fitzgerald
Mallinckrodt
Deloitte
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.